Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(4-iodophenyl)-1-(4-(2-pyrrolidinoethoxy)phenyl)-2-phenyl-1-butene
2. 4-iodopyrrolidinotamoxifen
3. Pyr-i-tam
4. Pyrrolidino-4-iodotamoxifen
1. 116057-75-1
2. (e)-1-(2-(4-(1-(4-iodophenyl)-2-phenylbut-1-en-1-yl)phenoxy)ethyl)pyrrolidine
3. Sb-223030
4. Cb 7432
5. Cb-7432
6. 1-[2-[4-[(e)-1-(4-iodophenyl)-2-phenylbut-1-enyl]phenoxy]ethyl]pyrrolidine
7. 456uxe9867
8. Iodoxifene
9. Pyrrolidine, 1-(2-(4-(1-(4-iodophenyl)-2-phenyl-1-butenyl)phenoxy)ethyl-, (e)-
10. Pyrrolidino-4-iodotamoxifen
11. Idoxifene [usan:inn:ban]
12. Cis-idoxifene
13. Sb 223030
14. Unii-456uxe9867
15. Idoxifene [inn]
16. Idoxifene [mi]
17. Idoxifene (usan/inn)
18. Idoxifene [usan]
19. Idoxifene [mart.]
20. (e)-1-(2-(4-(1-(4-iodophenyl)-2-phenyl-1-butenyl)phenoxy)ethyl)pyrrolidine
21. Chembl6318
22. Schembl19216
23. Bidd:er0017
24. Dtxsid5043926
25. Chebi:188870
26. Zinc1533058
27. Bdbm50219403
28. Hy-u00178
29. 1-(2-(p-((e)-beta-ethyl-alpha-(p-iodophenyl)styryl)phenoxy)ethyl)pyrrolidine
30. Akos016013971
31. Cs-7245
32. Pyrrolidine, 1-(2-(4-(1-(4-iodophenyl)-2-phenyl-1-butenyl)phenoxy)ethyl)-, (e)-
33. D04496
34. A854422
35. Q5989541
36. 1-(4-iodophenyl)-1-[4-(2-pyrrolizinoethoxy)phenyl]-2-phenyl-1-butene
37. Trans-1-(4-iodophenyl)-1-(4-(2'-pyrrolidinoethoxy)phenyl)-2-phenylbutene
38. (e)-1-(2-(4-(1-(4-iodophenyl)-2-phenylbut-1-enyl)phenoxy)ethyl)pyrrolidine
39. 1-(2-(p-((e)-.beta.-ethyl-.alpha.-(p-iodophenyl)styryl)phenoxy)ethyl)pyrrolidine
| Molecular Weight | 523.4 g/mol |
|---|---|
| Molecular Formula | C28H30INO |
| XLogP3 | 8.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 8 |
| Exact Mass | 523.13721 g/mol |
| Monoisotopic Mass | 523.13721 g/mol |
| Topological Polar Surface Area | 12.5 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 547 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Estrogen Antagonists
Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)
INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Idoxifene manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idoxifene, including repackagers and relabelers. The FDA regulates Idoxifene manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idoxifene API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Idoxifene supplier is an individual or a company that provides Idoxifene active pharmaceutical ingredient (API) or Idoxifene finished formulations upon request. The Idoxifene suppliers may include Idoxifene API manufacturers, exporters, distributors and traders.
Idoxifene Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Idoxifene GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Idoxifene GMP manufacturer or Idoxifene GMP API supplier for your needs.
A Idoxifene CoA (Certificate of Analysis) is a formal document that attests to Idoxifene's compliance with Idoxifene specifications and serves as a tool for batch-level quality control.
Idoxifene CoA mostly includes findings from lab analyses of a specific batch. For each Idoxifene CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Idoxifene may be tested according to a variety of international standards, such as European Pharmacopoeia (Idoxifene EP), Idoxifene JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Idoxifene USP).
LOOKING FOR A SUPPLIER?
